How likely is it to test positive for a pathogenic variant with GeneMate®?
Among those who underwent testing with GeneMate®, 8% tested positive for a pathogenic variant. Of those who tested positive, 35% had a known pathogenic variant in the family. For the rest the information was new.
New guidelines for hereditary breast cancer
Revised clinical guidelines for breast cancer were published May 10, 2022, with significant changes.
Monogenic vs Polygenic Inheritance
Monogenic inheritance means that a disease is caused by a pathogenic genetic variant in a single gene. These variants, as well as the diseases or syndromes they cause, are rare in the general population.
Is blood cancer hereditary?
Cancers in the blood cells, bone marrow (where blood cells are made), or lymphatic system are together called blood cancers.
Finally Kristina was able to get tested
When Kristina was just 13 years old, her mom was diagnosed with breast cancer. Her maternal grandmother had lost her battle with breast cancer a few years prior
iCellate launches collaboration with football player Olivia Schough
Cancer diagnostics company iCellate Medical AB announces collaboration with football star Olivia Schough.
Project ELEVATE initiates clinical trial for development of novel cancer diagnostics
Dr. Susanne Sebens at the Institute of Experimental Cancer Research (IET) at the University of Kiel are proud to announce that the clinical trial for their joint project ELEVATE
Which genetic variants cause disease?
While writing about genetic variants we use the terms benign, pathogenic, and variant of unknown significance (VUS).
Mapping your family cancer history
The importance of family cancer history and how to map it
Hereditary stomach cancer
Stomach cancer is the fifth most common cancer in the world, and 10-20% is hereditary
What to expect from your GeneMate® test
In this blog post we will walk you through the various possible outcomes of your GeneMate® test.
Behind the scenes of GeneMate®
Ever wonder what happens to your saliva sample after returning it to iCellate's lab?
The importance of informing family members of a positive result
All first-degree relatives of a carrier have a 50% risk of themselves being a carrier
Melanoma is the most rapidly increasing cancer in Sweden and 10-15% of all cases are hereditary
Which genes does GeneMate® test and why?
Our clinically actionable selection of genes gives you a better shot at prevention.
Hereditary prostate cancer
1 in 5 Swedish men will be diagnosed with prostate cancer. Guidelines for the identification of hereditary prostate cancer are now expanded.
Hereditary cancer: 97% of all carriers remain unidentified
Family history-based testing identifies some, misses many
Polyposis' cause, associated cancer types, and risk-reducing measures
iCellate’s lab receives ISO 15189 certification by Swedac
iCellate is the only Swedish company that holds an ISO 15189 certification within cancer diagnostics.
Lynch syndrom is caused by hereditary pathogenic variants and increases the risk of several different cancer types
Things to consider prior to genetic testing
There may be several reasons you wish to take a genetic test.